{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T04:03:13Z","timestamp":1746244993684,"version":"3.40.4"},"reference-count":65,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.neuint.2014.03.016","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T02:47:21Z","timestamp":1396579641000},"page":"36-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Reverse microdialysis of a 5-HT2A receptor antagonist alters extracellular glutamate levels in the striatum of the MPTP mouse model of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"71","author":[{"given":"Marcus C.","family":"Ferguson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tultul","family":"Nayyar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Twum A.","family":"Ansah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2014.03.016_b0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0028-3908(97)00051-8","article-title":"Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells","volume":"36","author":"Aghajanian","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2014.03.016_b0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0006-8993(99)01224-X","article-title":"Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release","volume":"825","author":"Aghajanian","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2014.03.016_b0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0924-977X(03)00004-X","article-title":"Anti-cataleptic effects of clozapine, but not olanzapine and quetiapine, on SCH 23390- or raclopride-induced catalepsy in rats","volume":"13","author":"Ahlqvist","year":"2003","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuint.2014.03.016_b0020","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.1090","article-title":"Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature","volume":"16","author":"Ahlskog","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2014.03.016_b0025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/neur.1996.0018","article-title":"Synaptic plasticity in the caudate nucleus of patients with Parkinson\u2019s disease","volume":"5","author":"Anglade","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.neuint.2014.03.016_b0030","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1471-4159.2004.02714.x","article-title":"Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors","volume":"91","author":"Auclair","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2014.03.016_b0035","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/1098-2396(20010315)39:4<297::AID-SYN1012>3.0.CO;2-Q","article-title":"Distribution of serotonin 5-HT(2A) receptors in afferents of the rat striatum","volume":"39","author":"Bubser","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.neuint.2014.03.016_b0040","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1471-4159.2007.05185.x","article-title":"Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson\u2019s disease, the MPTP-intoxicated mouse","volume":"105","author":"Chassain","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2014.03.016_b0045","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/cne.21852","article-title":"Downregulation of glial glutamate transporters after dopamine denervation in the striatum of 6-hydroxydopamine-lesioned rats","volume":"511","author":"Chung","year":"2008","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuint.2014.03.016_b0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-2999(03)01352-9","article-title":"Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats","volume":"464","author":"Corsi","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2014.03.016_b0055","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2014.03.016_b0060","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1471-4159.1999.0731033.x","article-title":"Role of serotonin(2A) and serotonin(2B\/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation","volume":"73","author":"De Deurwaerdere","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2014.03.016_b0065","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0079-6123(08)00921-7","article-title":"Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson\u2019s disease and other motor disorders","volume":"172","author":"Di Matteo","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuint.2014.03.016_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb07458.x","article-title":"Description of Parkinson\u2019s disease as a clinical syndrome","volume":"991","author":"Fahn","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuint.2014.03.016_b0075","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neuropharm.2010.03.013","article-title":"5-HT2A receptor antagonists improve motor impairments in the MPTP mouse model of Parkinson\u2019s disease","volume":"59","author":"Ferguson","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2014.03.016_b0080","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1046\/j.1460-9568.2003.02795.x","article-title":"The effect of 6-hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysis","volume":"18","author":"Galeffi","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2014.03.016_b0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0028-3908(98)00188-9","article-title":"Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats","volume":"38","author":"Gobert","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2014.03.016_b0090","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1098-2396(20000601)36:3<205::AID-SYN5>3.0.CO;2-D","article-title":"Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat","volume":"36","author":"Gobert","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.neuint.2014.03.016_b0095","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuroscience.2005.08.003","article-title":"L-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"136","author":"Holmer","year":"2005","journal-title":"Neuroscience"},{"issue":"194","key":"10.1016\/j.neuint.2014.03.016_b0100","article-title":"5-HT2A receptor levels increase in MPTP-lesioned macaques treated chronically with L-DOPA","volume":"33","author":"Huot","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2014.03.016_b0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/exnr.1996.6380","article-title":"Problems with current pharmacologic treatment of Parkinson\u2019s disease","volume":"144","author":"Hurtig","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2014.03.016_b0110","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0006-8993(95)00865-N","article-title":"DOI, a 5-HT2A\/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum","volume":"698","author":"Ichikawa","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2014.03.016_b0115","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1523\/JNEUROSCI.18-12-04732.1998","article-title":"Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway","volume":"18","author":"Ingham","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2014.03.016_b0120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00227776","article-title":"Morphological changes in the rat neostriatum after unilateral 6-hydroxydopamine injections into the nigrostriatal pathway","volume":"93","author":"Ingham","year":"1993","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuint.2014.03.016_b0125","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0006-8993(01)03147-X","article-title":"MK801 suppresses the L-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats","volume":"926","author":"Jonkers","year":"2002","journal-title":"Brain Res."},{"issue":"Suppl 4","key":"10.1016\/j.neuint.2014.03.016_b0130","doi-asserted-by":"crossref","first-page":"S397","DOI":"10.1016\/S0924-977X(01)00109-2","article-title":"Extrapyramidal side effects are unacceptable","volume":"11","author":"Kane","year":"2001","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuint.2014.03.016_b0135","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0006-8993(03)02516-2","article-title":"5-HT 2A receptor stimulation by DOI, a 5-HT 2A\/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens","volume":"972","author":"Kuroki","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2014.03.016_b0140","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","article-title":"Parkinson\u2019s disease. First of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuint.2014.03.016_b0145","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1046\/j.1471-4159.2001.00644.x","article-title":"Nigrostriatal denervation does not affect glutamate transporter mRNA expression but subsequent levodopa treatment selectively increases GLT1 mRNA and protein expression in the rat striatum","volume":"79","author":"Lievens","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2014.03.016_b0150","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0304-3940(90)90463-J","article-title":"Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons","volume":"115","author":"Lindefors","year":"1990","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2014.03.016_b0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s002130050265","article-title":"8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A\/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release","volume":"131","author":"Lucas","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuint.2014.03.016_b0160","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1046\/j.1471-4159.2000.740693.x","article-title":"Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum","volume":"74","author":"Lucas","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2014.03.016_b0165","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.nbd.2003.12.007","article-title":"Glutamate transporters: animal models to neurologic disease","volume":"15","author":"Maragakis","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2014.03.016_b0170","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.neuint.2010.07.004","article-title":"Time-dependent changes in GLT-1 functioning in striatum of hemi-Parkinson rats","volume":"57","author":"Massie","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2014.03.016_b9000","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0306-4522(89)90128-0","article-title":"The organization of the projection from the cerebral cortex to the striatum in the rat","volume":"29","author":"McGeorge","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2014.03.016_b0175","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/schbul\/17.2.263","article-title":"The mechanism of action of novel antipsychotic drugs","volume":"17","author":"Meltzer","year":"1991","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuint.2014.03.016_b0180","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/(SICI)1098-2396(200005)36:2<129::AID-SYN6>3.0.CO;2-4","article-title":"Haloperidol reverses the changes in striatal glutamatergic immunolabeling following a 6-OHDA lesion","volume":"36","author":"Meshul","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.neuint.2014.03.016_b0185","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1006\/exnr.2000.7467","article-title":"Alterations in rat striatal glutamate synapses following a lesion of the cortico- and\/or nigrostriatal pathway","volume":"165","author":"Meshul","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2014.03.016_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0306-4522(98)00189-4","article-title":"Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion","volume":"88","author":"Meshul","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2014.03.016_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-9861(19971208)389:1<1::AID-CNE1>3.0.CO;2-6","article-title":"Regional and cellular distribution of serotonin 5-hydroxytryptamine2a receptor mRNA in the nucleus accumbens, olfactory tubercle, and caudate putamen of the rat","volume":"389","author":"Mijnster","year":"1997","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuint.2014.03.016_b0200","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00008877-200006000-00014","article-title":"Low-dose clozapine pretreatment partially prevents haloperidol-induced deficits in conditioned active avoidance","volume":"11","author":"Murphy","year":"2000","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuint.2014.03.016_b0205","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1460-9568.2009.06806.x","article-title":"Cortical serotonin and norepinephrine denervation in parkinsonism: preferential loss of the beaded serotonin innervation","volume":"30","author":"Nayyar","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2014.03.016_b0210","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1212\/WNL.40.2.340","article-title":"Levodopa-induced dyskinesia: review, observations, and speculations","volume":"40","author":"Nutt","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2014.03.016_b0215","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJMcp043908","article-title":"Clinical practice. Diagnosis and initial management of Parkinson\u2019s disease","volume":"353","author":"Nutt","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuint.2014.03.016_b0220","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1471-1931(00)00031-8","article-title":"Levodopa motor complications in Parkinson\u2019s disease","volume":"23","author":"Obeso","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuint.2014.03.016_b0225","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0169-328X(94)90223-2","article-title":"Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors","volume":"23","author":"Pompeiano","year":"1994","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuint.2014.03.016_b0230","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0893-133X(01)00333-5","article-title":"5-HT2A and 5-HT2C\/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum","volume":"26","author":"Porras","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuint.2014.03.016_b0235","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/j.1460-9568.2011.07675.x","article-title":"Brain 5-HT(2A) receptors in MPTP monkeys and levodopa-induced dyskinesias","volume":"33","author":"Riahi","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2014.03.016_b0240","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1460-9568.2004.03591.x","article-title":"Chronic L-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson\u2019s disease","volume":"20","author":"Robelet","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2014.03.016_b0245","first-page":"653","article-title":"ACP-103, a 5-HT2A receptor inverse agonist","volume":"7","author":"Roberts","year":"2006","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.neuint.2014.03.016_b0250","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0014-4886(02)00050-X","article-title":"Acute and subchronic MPTP administration differentially affects striatal glutamate synaptic function","volume":"180","author":"Robinson","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2014.03.016_b0255","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0022-3565(25)13106-6","article-title":"Regional effects of MK-801 on dopamine release: effects of competitive NMDA or 5-HT2A receptor blockade","volume":"277","author":"Schmidt","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuint.2014.03.016_b0260","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1046\/j.1471-4159.1994.62041382.x","article-title":"Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine","volume":"62","author":"Schmidt","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2014.03.016_b0265","doi-asserted-by":"crossref","first-page":"8846","DOI":"10.1523\/JNEUROSCI.20-23-08846.2000","article-title":"DOI-Induced activation of the cortex: dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons","volume":"20","author":"Scruggs","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2014.03.016_b0270","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0304-3940(03)00547-0","article-title":"The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats","volume":"346","author":"Scruggs","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2014.03.016_b0275","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuint.2007.03.012","article-title":"The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention","volume":"51","author":"Sheldon","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2014.03.016_b0280","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0022-3565(25)38366-7","article-title":"Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies","volume":"266","author":"Sorensen","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuint.2014.03.016_b0285","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1471-4159.2003.01553.x","article-title":"The \u2018glial\u2019 glutamate transporter, EAAT2 (Glt-1) accounts for high affinity glutamate uptake into adult rodent nerve endings","volume":"84","author":"Suchak","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2014.03.016_b0290","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.neuropharm.2005.12.004","article-title":"Serotonin 2A receptor antagonist treatment reduces dopamine D1 receptor-mediated rotational behavior but not L-DOPA-induced abnormal involuntary movements in the unilateral dopamine-depleted rat","volume":"50","author":"Taylor","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2014.03.016_b0295","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.pbb.2008.04.010","article-title":"A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model","volume":"90","author":"Vanover","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuint.2014.03.016_b0300","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/WNR.0b013e32832ad556","article-title":"Effects of subthalamic nucleus lesions and stimulation upon glutamate levels in the dopamine-depleted rat striatum","volume":"20","author":"Walker","year":"2009","journal-title":"NeuroReport"},{"key":"10.1016\/j.neuint.2014.03.016_b0305","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/(SICI)1096-9861(19960701)370:3<405::AID-CNE10>3.0.CO;2-R","article-title":"Colocalization of serotonin receptor subtypes 5-HT2A, 5-HT2C, and 5-HT6 with neuropeptides in rat striatum","volume":"370","author":"Ward","year":"1996","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuint.2014.03.016_b0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cne.902960102","article-title":"Unbiased stereological estimation of the number of neurons in the human hippocampus","volume":"296","author":"West","year":"1990","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuint.2014.03.016_b0315","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/BF00169306","article-title":"The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis","volume":"336","author":"Westerink","year":"1987","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.neuint.2014.03.016_b0320","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s002130051001","article-title":"Clozapine pretreatment modifies haloperidol-elicited forebrain Fos induction: a regionally-specific double dissociation","volume":"144","author":"Young","year":"1999","journal-title":"Psychopharmacology"}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018614000795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018614000795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T07:35:14Z","timestamp":1746171314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018614000795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":65,"alternative-id":["S0197018614000795"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2014.03.016","relation":{},"ISSN":["0197-0186"],"issn-type":[{"type":"print","value":"0197-0186"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reverse microdialysis of a 5-HT2A receptor antagonist alters extracellular glutamate levels in the striatum of the MPTP mouse model of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2014.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}